174 related articles for article (PubMed ID: 36524011)
1. Noscapine-Amino Acid Conjugates Suppress the Progression of Cancer Cells.
Awasthi A; Kumar N; Mishra A; Ravi R; Dalal A; Shankar S; Chandra R
ACS Pharmacol Transl Sci; 2022 Dec; 5(12):1292-1304. PubMed ID: 36524011
[TBL] [Abstract][Full Text] [Related]
2. Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine.
Nambiar N; Nagireddy PKR; Pedapati R; Kantevari S; Lopus M
Life Sci; 2020 Oct; 258():118238. PubMed ID: 32791146
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Functional Studies on Noscapine and Cotarnine Amino Acid Derivatives as Antitumor Agents.
Davarzani Z; Salehi P; Asghari SM; Bararjanian M; Hamrahi Mohsen A; Dehghan Harati H
ACS Omega; 2023 Dec; 8(48):45502-45509. PubMed ID: 38075843
[TBL] [Abstract][Full Text] [Related]
4. Imidazo[2,1-
Nagireddy PKR; Kommalapati VK; Siva Krishna V; Sriram D; Tangutur AD; Kantevari S
ACS Omega; 2019 Nov; 4(21):19382-19398. PubMed ID: 31763563
[TBL] [Abstract][Full Text] [Related]
5. Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents.
Manchukonda NK; Naik PK; Santoshi S; Lopus M; Joseph S; Sridhar B; Kantevari S
PLoS One; 2013; 8(10):e77970. PubMed ID: 24205049
[TBL] [Abstract][Full Text] [Related]
6. Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
Mishra RC; Karna P; Gundala SR; Pannu V; Stanton RA; Gupta KK; Robinson MH; Lopus M; Wilson L; Henary M; Aneja R
Biochem Pharmacol; 2011 Jul; 82(2):110-21. PubMed ID: 21501599
[TBL] [Abstract][Full Text] [Related]
7. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
8. Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel.
Dash SG; Suri C; Nagireddy PKR; Kantevari S; Naik PK
J Biomol Struct Dyn; 2021 Sep; 39(14):5276-5289. PubMed ID: 32608323
[TBL] [Abstract][Full Text] [Related]
9. A Comprehension into Target Binding and Spatial Fingerprints of Noscapinoid Analogues as Inhibitors of Tubulin.
Mandavi S; Verma SK; Banjare L; Dubey A; Bhatt R; Thareja S; Jain AK
Med Chem; 2021; 17(6):611-622. PubMed ID: 31951171
[TBL] [Abstract][Full Text] [Related]
10. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells.
Dash SG; Kantevari S; Pandey SK; Naik PK
Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169
[TBL] [Abstract][Full Text] [Related]
12. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
[TBL] [Abstract][Full Text] [Related]
13. Imperative persistent interaction analysis of anticancer noscapine-ionic liquid with calf thymus DNA.
Sehrawat H; Kumar N; Panchal S; Kumar L; Chandra R
Int J Biol Macromol; 2022 Nov; 220():415-425. PubMed ID: 35985396
[TBL] [Abstract][Full Text] [Related]
14. Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer.
Suri C; Naik PK
SAR QSAR Environ Res; 2015 Jun; 26(6):507-19. PubMed ID: 26274780
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
[TBL] [Abstract][Full Text] [Related]
16. A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.
Ghaly PE; Abou El-Magd RM; Churchill CD; Tuszynski JA; West FG
Oncotarget; 2016 Jun; 7(26):40518-40530. PubMed ID: 27777381
[TBL] [Abstract][Full Text] [Related]
17. 9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer.
Nagireddy PKR; Kumar D; Kommalapati VK; Pedapati RK; Kojja V; Tangutur AD; Kantevari S
Drug Dev Res; 2022 May; 83(3):605-614. PubMed ID: 34612529
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.
Zhou J; Gupta K; Yao J; Ye K; Panda D; Giannakakou P; Joshi HC
J Biol Chem; 2002 Oct; 277(42):39777-85. PubMed ID: 12183452
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling reveals binding interface of γ-tubulin with GCP4 and interactions with noscapinoids.
Suri C; Joshi HC; Naik PK
Proteins; 2015 May; 83(5):827-43. PubMed ID: 25662919
[TBL] [Abstract][Full Text] [Related]
20. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]